GPC5 regulates human umbilical cord mesenchymal stem cell function and exosome signaling mediates AhR pathway repair of cigarette smoke induced lung injury.
Abstract
Cigarette smoking (CS) is a major cause of chronic lung injury. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and secreted exosomes (exos) hold therapeutic potential for lung repair. However, improving hUC-MSCs utilization remains a crucial clinical issue. Glypican-5 (GPC5) was recently found to participate in stem cell fate. This study investigated the role of GPC5 in regulating hUC-MSC function and exosome-mediated repair of cigarette smoke extract (CSE)-induced injury. GPC5 gain-of- and loss-of-function assays were performed using hUC-MSCs. The repair effect of hUC-MSCs on CSE-induced human pulmonary microvascular endothelial cell (HPMEC) injury was enhanced by GPC5 overexpression. CCK-8, Transwell, flow cytometry, ELISA, FITC-dextran detections were utilized for measuring cell function, inflammatory response and permeability alteration. The results showed that the exos secreted from hUC-MSCs carried increased GPC5 and strengthened HPMEC repair under CSE exposure. Moreover, improving the activity and promoting the nuclear retention of aryl hydrocarbon receptor (AhR) was an important potential mechanism of GPC5 derived from hUC-MSC-exo in repairing CSE-HPMEC injury. Finally, a CS mouse model receiving GPC5-modified hUC-MSCs transplantation showed effective improvements in lung function injury, alveolar structure damage, collagen deposition and inflammatory cell infiltration. In conclusion, GPC5 is a key regulator of hUC-MSC function and exosome efficacy and hUC-MSC-derived exos enriched with GPC5 mitigated CSE-induced lung injury via modulating the AhR pathway in endothelial cells. This study provides a novel molecular target and therapeutic strategy for CS-related lung injury.